Despite observing a favorable trend, such as a 21% reduction in risk, statistical significance was not attained 34 .
← all excerpts
Exploring the clinical effectiveness of glucagon-like peptide-1 receptor agonists in managing cardiovascular complications: an updated comprehensive review and future directives.
1
—
—